John Diekman
InvestorFounding and Managing Partner at 5AM Ventures
Menlo Park, California
Writes $100K – $5M checks · typically $1.5M
About
John Diekman, a Princeton- and Stanford-trained chemist, uniquely combines building platform biotech companies and investing—he led Affymetrix, ran Affymax, founded two venture firms, and chairs research institutions.
Invests in
BiotechHealthtechMedical Devices
Experience
- 5AM VenturesManaging Partner
Shared employers
Also worked at 5AM Ventures1
Deals · 2
Ideaya BiosciencesBoard seat
via 5AM Ventures · filed May 2018 · $94M raise
Igenica BiotherapeuticsBoard seat
via 5AM Ventures · filed Jan 2015 · $6.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at 5AM Ventures
Alex Wareham
Management Company Controller at 5AM Ventures
Andy Schwab
Managing Partner at 5AM Ventures
Aniqa Tasnim
Senior Associate at 5AM Ventures
Anna Yaeger
Chief Investment Officer and Partner at 5AM Ventures
Arthur Tzianabos
Venture Partner at 5AM Ventures
Bella Nittolo
Administrative Assistant and Office Manager at 5AM Ventures
Brian Daniels
Venture Partner at 5AM Ventures
Britt Inga Emerson
Associate Director, Investor Relations at 5AM Ventures
Network3
Andy Schwab
Managing Partner at 5AM Ventures
Brian Daniels
Venture Partner at 5AM Ventures
Deborah Palestrant
Partner, Executive Chair, 4:59 Initiative at 5AM Ventures
Investors connected to John in public investor directories — a warm-intro map.